Globe Life Inc. $GL Shares Sold by Stephens Inc. AR

Stephens Inc. AR cut its stake in shares of Globe Life Inc. (NYSE:GL) by 82.9% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 4,806 shares of the company’s stock after selling 23,255 shares during the quarter. Stephens Inc. AR’s holdings in Globe Life were worth $597,000 as of its most recent SEC filing.

Other hedge funds have also recently modified their holdings of the company. Global Assets Advisory LLC acquired a new stake in shares of Globe Life during the second quarter worth $25,000. AdvisorNet Financial Inc lifted its holdings in shares of Globe Life by 60.0% during the second quarter. AdvisorNet Financial Inc now owns 224 shares of the company’s stock worth $28,000 after purchasing an additional 84 shares during the period. TD Private Client Wealth LLC acquired a new stake in shares of Globe Life during the second quarter worth $39,000. SouthState Corp acquired a new stake in shares of Globe Life during the first quarter worth $43,000. Finally, Ransom Advisory Ltd acquired a new stake in shares of Globe Life during the first quarter worth $50,000. 81.61% of the stock is owned by institutional investors and hedge funds.

Globe Life Trading Down 1.5%

Shares of GL stock opened at $133.67 on Friday. Globe Life Inc. has a fifty-two week low of $100.27 and a fifty-two week high of $147.83. The stock has a market cap of $10.83 billion, a P/E ratio of 9.69 and a beta of 0.55. The business has a fifty day simple moving average of $139.54 and a 200-day simple moving average of $129.57. The company has a quick ratio of 0.06, a current ratio of 0.06 and a debt-to-equity ratio of 0.43.

Globe Life (NYSE:GL) last announced its quarterly earnings results on Wednesday, October 22nd. The company reported $4.81 earnings per share for the quarter, beating analysts’ consensus estimates of $4.54 by $0.27. Globe Life had a return on equity of 22.12% and a net margin of 19.36%.The business had revenue of $1.51 billion during the quarter, compared to analysts’ expectations of $1.52 billion. During the same quarter last year, the business posted $3.44 earnings per share. Globe Life has set its FY 2026 guidance at 14.600-15.300 EPS. FY 2025 guidance at 14.400-14.600 EPS. On average, analysts forecast that Globe Life Inc. will post 13.87 earnings per share for the current fiscal year.

Globe Life Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Friday, October 3rd will be given a dividend of $0.27 per share. This represents a $1.08 dividend on an annualized basis and a yield of 0.8%. The ex-dividend date is Friday, October 3rd. Globe Life’s dividend payout ratio (DPR) is currently 7.83%.

Insider Buying and Selling

In related news, EVP Michael Clay Majors sold 10,000 shares of Globe Life stock in a transaction dated Friday, August 1st. The stock was sold at an average price of $137.41, for a total transaction of $1,374,100.00. Following the completion of the sale, the executive vice president owned 47,066 shares in the company, valued at approximately $6,467,339.06. This trade represents a 17.52% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CFO Thomas Peter Kalmbach sold 28,952 shares of Globe Life stock in a transaction dated Tuesday, July 29th. The stock was sold at an average price of $140.97, for a total value of $4,081,363.44. Following the sale, the chief financial officer owned 30,665 shares of the company’s stock, valued at approximately $4,322,845.05. This represents a 48.56% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 51,452 shares of company stock worth $7,222,713. 1.51% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

A number of equities research analysts have commented on the company. Weiss Ratings reissued a “buy (b-)” rating on shares of Globe Life in a report on Saturday. BMO Capital Markets reissued a “market perform” rating and issued a $149.00 target price (up previously from $114.00) on shares of Globe Life in a report on Wednesday, July 30th. Keefe, Bruyette & Woods raised their target price on Globe Life from $145.00 to $155.00 and gave the company an “outperform” rating in a report on Monday, July 28th. Cfra Research raised Globe Life to a “moderate buy” rating in a report on Friday, July 25th. Finally, Truist Financial raised their target price on Globe Life from $150.00 to $158.00 and gave the company a “buy” rating in a report on Friday. Eight research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. According to MarketBeat.com, Globe Life has a consensus rating of “Moderate Buy” and an average price target of $152.78.

About Globe Life

Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.